VERISMO THERAPEUTICS

verismo-therapeutics-logo

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural stimulation” to T cells without triggering the T-cell exhaustion for the treatment of solid tumors. The lead therapy candidates in preclinical development are targeting pancreatic cancer, mesothelioma, and ovarian cancer.

#SimilarOrganizations #People #Financial #Event #Website #More

VERISMO THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2020-01-01

Address:
Philadelphia, Pennsylvania, United States

Country:
United States

Website Url:
http://www.verismotherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
215-989-4225

Email Addresses:
[email protected]

Total Funding:
40 M USD

Technology used in webpage:
Euro GoDaddy


Similar Organizations

amber-therapeutics-logo

Amber Therapeutics

Amber Therapeutics develops the next-generation of bioelectrical therapies.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

catalym-logo

Catalym

Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.

clarapath-logo

Clarapath

We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.

eyebiotech-logo

Eyebiotech

Eyebiotech is a privately held ophthalmology biotechnology company.

headspace-health-logo

Headspace Health

Headspace is a digital health platform that provides guided meditation sessions and mindfulness training.

jogo-health-logo

JOGO Health

JOGO Health is a biotech company focused on digital therepeutics for neuromuscular conditions.

q-bio-logo

Q Bio

On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone

rona-therapeutics-logo

Rona Therapeutics

Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.

Current Employees Featured

not_available_image

Pavel Aprelev
Pavel Aprelev Director of Corporate Development @ Verismo Therapeutics
Director of Corporate Development
2020-01-01

michael-c-milone_image

Michael C. Milone
Michael C. Milone Co-Founder, Co-Chairman of Scientific Advisory Board @ Verismo Therapeutics
Co-Founder, Co-Chairman of Scientific Advisory Board

bryan-kim_image

Bryan Kim
Bryan Kim Co-Founder and CEO @ Verismo Therapeutics
Co-Founder and CEO

laura-johnson_image

Laura Johnson
Laura Johnson Chief Scientific Officer @ Verismo Therapeutics
Chief Scientific Officer
2021-07-01

donald-l-siegel_image

Donald L. Siegel
Donald L. Siegel Co-Founder, Co-Chairman of Scientific Advisory Board @ Verismo Therapeutics
Co-Founder, Co-Chairman of Scientific Advisory Board

sara-weiss_image

Sara Weiss
Sara Weiss Senior Vice President of Clinical Operations @ Verismo Therapeutics
Senior Vice President of Clinical Operations
2023-05-01

not_available_image

Mala Talekar
Mala Talekar Vice President of Clinical Development @ Verismo Therapeutics
Vice President of Clinical Development
2023-07-01

Founder


bryan-kim_image

Bryan Kim

donald-l-siegel_image

Donald L. Siegel

michael-c-milone_image

Michael C. Milone

Investors List

dongkoo-bio-pharm-co-ltd_image

DongKoo Bio&Pharma

DongKoo Bio&Pharma investment in Seed Round - Verismo Therapeutics

hong-leong-bank_image

Hong Leong Bank

Hong Leong Bank investment in Seed Round - Verismo Therapeutics

brv-capital-management_image

BRV Capital Management

BRV Capital Management investment in Seed Round - Verismo Therapeutics

Official Site Inspections

http://www.verismotherapeutics.com Semrush global rank: 13.24 M Semrush visits lastest month: 78

  • Host name: 245.105.62.166.host.secureserver.net
  • IP address: 166.62.105.245
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Verismo Therapeutics"

Verismo Therapeutics - Crunchbase Company Profile

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural stimulation” to T …See details»

verismotherapeutics.com Reviews: Is this site a scam or legit?

While some are self-explanatory concerning verismotherapeutics.com, let's dive deeper into the remaining ones. Proximity to Potentially Harmful Websites. This metric gauges the connection, …See details»

Verismo Therapeutics Company Profile | Management and

Company Name. Verismo Therapeutics. Main Industry. Research & Development, Business Services. Website. www.verismotherapeutics.comSee details»

Verismo Therapeutics - LinkedIn

Verismo Therapeutics, a clinical-stage biotechnology company developing the novel KIR-CAR platform for solid tumors and blood cancers, today announced a strategic investment from IFLI …See details»

VERISMO THERAPEUTICS, INC. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for VERISMO THERAPEUTICS, INC. of Philadelphia, PA. Get the latest business insights from Dun & …See details»

Verismo Therapeutics - PitchBook

Verismo Therapeutics General Information Description. Developer of cancer therapeutics designed to improve persistence and efficacy against solid tumor models. The company …See details»

Verismo Therapeutics Company Overview, Contact Details

[email protected]: 50%. [email protected]: [email protected]: 50%. See more formats. Frequently Asked Questions …See details»

Verismo Therapeutics - Overview, News & Similar companies

Verismo Therapeutics contact info: Phone number: (215) 989-4225 Website: www.verismotherapeutics.com What does Verismo Therapeutics do? Verismo Therapeutics is …See details»

Verismo Therapeutics - Craft

Verismo Therapeutics is a company that develops a KIR-CAR platform for cancer treatment. Its technology is based on chimeric antigen receptors (CAR) T-cell therapy for solid tumors …See details»

Verismo Therapeutics - Contacts, Employees, Board Members, …

Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.See details»

Verismo Therapeutics - Products, Competitors, Financials, …

Headquarters Location. 3675 Market Street Suite 200. Philadelphia, Pennsylvania, 19104, United States. 215-989-4225See details»

Verismo Therapeutics CEO and Key Executive Team | Craft.co

Verismo Therapeutics's Co-Founder and CEO/President is Bryan Kim. Other executives include Raymond Luke, Director of MSAT; Laura A Johnson, Chief Scientific Officer and 3 others. See …See details»

Team - Verismo Therapeutics: Defining a New Generation of KIR …

From Kymriah™ to SynKIR™ Verismo was founded by the inventors of Kymriah™, the first-ever FDA-approved CAR T cell therapy. This same team saw an opportunity to overcome the …See details»

Verismo Therapeutics Inc - Company Profile and News

Company profile page for Verismo Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»

Verismo Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Sep 7, 2023 Explore Verismo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 27 news, Disease Domain:Neoplasms, Endocrinology and …See details»

Join Us - Verismo

Start Your Career With Verismo. Verismo is transforming the treatment of solid tumors using nature-inspired multichain receptors. If you’re looking for a rewarding career experience fueled …See details»

Verismo Therapeutics - VentureRadar

Similar Companies: GAIA BioMedicine Unknown Privately Held GAIA BioMedicine, Inc., founded in 2015 as a spin-off venture of Kyushu University, is a technology-driven biopharmaceutical …See details»

Verismo Therapeutics Completes Merger to Accelerate Clinical …

Dec 20, 2024 For more information, visit: www.verismotherapeutics.com. About HLB Group. The HLB Group is comprised of HLB Inc. (KOSDAQ:028300) and its affiliates with a diverse …See details»

Verismo Therapeutics Announces $7 Million Pre-Series A with BRV …

Feb 28, 2023 Lead investor BRV Capital Management is joined by Ignite Innovation. PHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T …See details»

Verismo doses first subject in Phase I trial of SynKIR-310

4 hours ago Subjects will be divided into two cohorts, with each cohort consisting of three to six individuals. Credit: Volha_R/Shutterstock. Verismo Therapeutics has commenced the first …See details»

linkstock.net © 2022. All rights reserved